Skip to main content
OpenTrials
Completed

NCT Number: NCT01185678

Data on Oral Contraceptives Compliance in Non Stop Regimen

Adherence to the dosing scheme is the principal element of COC efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Contraception Behavior Health Behavior Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

18 year–50 year

Sex eligibility

Female

Study type

Observational

Primary location

Many Locations, Poland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients at the age of 18-50 requiring contraception, treated with oral contraceptives designed for the scheme 28 pills for 28 days. The decisions would be made at the discretion of the attending physician.

Exclusion criteria

  • Patients were not valid for analysis if the initial visit was before start of study in the country (retrospective documentation), or if they did not take oral contraceptives designed for the scheme 28 pills for 28 days.

Treatment and study plan

Qlaira or Yaz (BSP products defined as Combined Oral Contraceptive) and Cerazette or Azalia (competitor's products defined as Progestogen Only Pill)

Drug

One tablet per day, orally, 28 tablets per cycle, during three consecutive cycles.

Primary outcomes

  1. The percentage of users showing noncompliant behaviors

    Time frame: 3 consecutive cycles (28-days per cycle)

Secondary outcomes

  1. The characteristics of noncompliant behavior.

    Time frame: 3 consecutive cycles (28-days per cycle)

  2. The relation between noncompliant behavior and selected factors.

    Time frame: 3 consecutive cycles (28-days per cycle)

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Official study title

Observation of Compliance With Dosage in Women Using Oral Contraceptives Designed for the Non Stop Use, (it Means 28 Pills for 28-days Cycle).

Acronym: DOC Non Stop

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Aug 20, 2010
Registry last updated
Jun 27, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.